Back to CVE records
Medium 4.3HealthcarePublished Jun 2, 2026

CVE-2019-25717Dräger Infinity Delta/Kappa Patient Monitors Unauthenticated Log File Disclosure

Updated under an hour ago ()

Does this affect you?

It affects Dräger Infinity Delta and 5 other products. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.20%, higher than 10% of scored CVEs.

Dräger Infinity Delta, Delta XL, and Kappa patient monitors contain an information disclosure vulnerability that allows unauthenticated network attackers to access log files over a network connection. Attackers can retrieve device internals, location information, and wired network configuration details from the exposed log files.

CVSS
4.3 MEDIUM (v3.1, CNA)CVSS:3.1/AV:A/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
Weakness (CWE)
CWE-538
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.20% (percentile 10)
Assigned by
VulnCheck
NVD analysis
Analyzed
Record last updated
Jul 15, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Dräger Infinity Delta
drager:infinity_delta (from the name)
all software versions
CNA record
Dräger Infinity Delta XL
drager:infinity_delta_xl (from the name)
all software versions
CNA record
Dräger Infinity Kappa
drager:infinity_kappa (from the name)
all software versions
CNA record
draeger infinity_delta_firmware
draeger:infinity_delta_firmware
all versions
NVD
draeger delta_xl_firmware
draeger:delta_xl_firmware
all versions
NVD
draeger kappa_firmware
draeger:kappa_firmware
all versions
NVD

References

  • vendor-advisory
  • third-party-advisory, vdb-entry

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.